Celsius Holdings, Inc. Reports Record First Quarter 2022 Financial Results
Celsius Holdings, Inc. (NASDAQ: CELH) reported a record revenue of $133.4 million for Q1 2022, a significant increase of 167% compared to $50.0 million in Q1 2021. Domestic revenue surged 217% to $123.5 million, while international revenue declined 10% to $9.9 million. The company continues to expand its presence in the fitness drink sector, backed by six clinically validated studies. The financial results will be discussed in a conference call scheduled for May 10, 2022, at 4:30 p.m. Eastern Time.
- Record Q1 2022 revenue of $133.4 million, up 167% from $50.0 million in Q1 2021.
- Domestic revenue increased 217% to $123.5 million.
- International revenue decreased 10% to $9.9 million.
Revenue of
Domestic revenue increased
International revenue decreased
BOCA RATON, Fla., May 10, 2022 /PRNewswire/ -- Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today reported preliminary financial results for the first quarter ended March 31, 2022. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss the results with the investment community.
A PDF containing our first quarter 2022 results and full financial tables is available at:
https://www.celsiusholdingsinc.com/Q1_2022/
To participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:
US: 877-709-8150
International: 201-689-8354
Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=tSbZnnGx
An audio replay of the call will be available on the Company's website at:
https://www.celsiusholdingsinc.com/press-releases/
Celsius Holdings, Inc. (Nasdaq: CELH), is a global consumer packaged goods company with a proprietary, clinically proven formula for its master brand CELSIUS®. A lifestyle energy drink born in fitness and a pioneer in the rapidly growing energy category. CELSIUS® offers proprietary, functional, essential energy formulas clinically-proven to offer significant health benefits to its users. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. For more information, please visit: http://www.celsiusholdingsinc.com
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases, you can identify these statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," "would," or similar words. You should not rely on forward-looking statements since Celsius Holdings' actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; the Company's ability to satisfy in a timely manner, all Securities and Exchange Commission (SEC) required filings and the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the rules and regulations adopted under that Section; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.
Investor Relations:
Cameron Donahue
(651) 707-3532
cdonahue@celsius.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/celsius-holdings-inc-reports-record-first-quarter-2022-financial-results-301544203.html
SOURCE Celsius Holdings, Inc.
FAQ
What were Celsius Holdings' Q1 2022 earnings results for CELH?
How did domestic and international revenue perform in Q1 2022 for CELH?
When is the conference call to discuss Celsius Holdings' Q1 2022 results?
